TLDR Umicore shares dropped nearly 11% after Belgian holding company GBL sold half its stake through an accelerated bookbuild GBL offloaded 19.6 million shares (8% of Umicore’s equity) at 15.35 euros per share, raising about 300 million euros The sale cuts GBL’s ownership from 16% to 8%, with the company agreeing to a 90-day lock-up [...] The post Umicore (UMI.BR) Stock Drops 11% as Major Investor Sells Half Its Position appeared first on CoinCentral.TLDR Umicore shares dropped nearly 11% after Belgian holding company GBL sold half its stake through an accelerated bookbuild GBL offloaded 19.6 million shares (8% of Umicore’s equity) at 15.35 euros per share, raising about 300 million euros The sale cuts GBL’s ownership from 16% to 8%, with the company agreeing to a 90-day lock-up [...] The post Umicore (UMI.BR) Stock Drops 11% as Major Investor Sells Half Its Position appeared first on CoinCentral.

Umicore (UMI.BR) Stock Drops 11% as Major Investor Sells Half Its Position

2025/11/18 18:15
3 min read

TLDR

  • Umicore shares dropped nearly 11% after Belgian holding company GBL sold half its stake through an accelerated bookbuild
  • GBL offloaded 19.6 million shares (8% of Umicore’s equity) at 15.35 euros per share, raising about 300 million euros
  • The sale cuts GBL’s ownership from 16% to 8%, with the company agreeing to a 90-day lock-up on its remaining stake
  • Umicore stock had rallied 62% year-to-date as of Monday’s close, topping the BEL 20 index in 2025
  • GBL stated the transaction aligns with its strategy to streamline holdings and focus on private assets

Umicore stock fell nearly 11% on Monday after Groep Brussel Lambert sold a large chunk of its holdings in the Belgian metals recycler.

Umicore SA (UMI.BR)Umicore SA (UMI.BR)

The drop marked Umicore’s worst trading day since March 2020. Shares hit their lowest level since early October.

GBL instructed Goldman Sachs to sell roughly 19.6 million shares through an accelerated bookbuild. The transaction represents about 8% of Umicore’s total equity.

The shares were priced at 15.35 euros each. That’s an 8.8% discount to Umicore’s Monday closing price of 16.83 euros.

The sale raised close to 300 million euros for GBL. Settlement is expected on November 20.

GBL’s ownership in Umicore dropped from approximately 16% to 8%. The Belgian holding company has agreed to a 90-day lock-up period on its remaining stake.

Strategic Portfolio Shift

GBL said the move fits with its plan to streamline its portfolio. The company wants to increase its focus on private assets.

The divestment brings GBL to roughly 85% of its 5-billion-euro target under its medium-term strategy. GBL confirmed it intends to remain a long-term supporter of Umicore despite cutting its position.

KBC Securities analysts said the timing made sense. They noted Umicore’s share price had recovered sharply this year.

The stock had gained around 62% as of Monday’s close. Umicore was the top performer on Belgium’s BEL 20 index in 2025 before the selloff.

Limited Impact on GBL

Pérez estimated the deal would have only a marginal effect on GBL’s net asset value. He projected a reduction of roughly 30 million euros, or about 0.2% of NAV.

On a per-share basis, the impact is similarly small at around 0.22 euros. That’s also about 0.2% of GBL’s value.

Based on these numbers, he expected a limited share price reaction in GBL stock. GBL shares fell just 0.68% on the day.

Pérez said the sale aligns with GBL’s strategy to recycle part of its listed portfolio into direct private investments. The NAV per share impact should remain minimal, he noted.

The analyst estimated the transaction should generate around 310 million euros in proceeds for GBL.

Umicore shares fell to the bottom of Belgium’s BEL 20 index on Monday. The index itself dropped 1.10% during the session.

The post Umicore (UMI.BR) Stock Drops 11% as Major Investor Sells Half Its Position appeared first on CoinCentral.

Market Opportunity
Major Logo
Major Price(MAJOR)
$0.07437
$0.07437$0.07437
+0.13%
USD
Major (MAJOR) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Cashing In On University Patents Means Giving Up On Our Innovation Future

Cashing In On University Patents Means Giving Up On Our Innovation Future

The post Cashing In On University Patents Means Giving Up On Our Innovation Future appeared on BitcoinEthereumNews.com. “It’s a raid on American innovation that would deliver pennies to the Treasury while kneecapping the very engine of our economic and medical progress,” writes Pipes. Getty Images Washington is addicted to taxing success. Now, Commerce Secretary Howard Lutnick is floating a plan to skim half the patent earnings from inventions developed at universities with federal funding. It’s being sold as a way to shore up programs like Social Security. In reality, it’s a raid on American innovation that would deliver pennies to the Treasury while kneecapping the very engine of our economic and medical progress. Yes, taxpayer dollars support early-stage research. But the real payoff comes later—in the jobs created, cures discovered, and industries launched when universities and private industry turn those discoveries into real products. By comparison, the sums at stake in patent licensing are trivial. Universities collectively earn only about $3.6 billion annually in patent income—less than the federal government spends on Social Security in a single day. Even confiscating half would barely register against a $6 trillion federal budget. And yet the damage from such a policy would be anything but trivial. The true return on taxpayer investment isn’t in licensing checks sent to Washington, but in the downstream economic activity that federally supported research unleashes. Thanks to the bipartisan Bayh-Dole Act of 1980, universities and private industry have powerful incentives to translate early-stage discoveries into real-world products. Before Bayh-Dole, the government hoarded patents from federally funded research, and fewer than 5% were ever licensed. Once universities could own and license their own inventions, innovation exploded. The result has been one of the best returns on investment in government history. Since 1996, university research has added nearly $2 trillion to U.S. industrial output, supported 6.5 million jobs, and launched more than 19,000 startups. Those companies pay…
Share
BitcoinEthereumNews2025/09/18 03:26
Spur Protocol Daily Quiz 21 February 2026: Claim Free Tokens and Boost Your Crypto Wallet

Spur Protocol Daily Quiz 21 February 2026: Claim Free Tokens and Boost Your Crypto Wallet

Spur Protocol Daily Quiz February 21 2026: Today’s Correct Answer and How to Earn Free In-App Tokens The Spur Protocol Daily Quiz for February 21, 2026, is
Share
Hokanews2026/02/21 17:10
Alex Acosta Tells Congress He Has No ‘Remorse’ For Jeffrey Epstein ‘Sweetheart Deal,’ Lawmaker Says

Alex Acosta Tells Congress He Has No ‘Remorse’ For Jeffrey Epstein ‘Sweetheart Deal,’ Lawmaker Says

The post Alex Acosta Tells Congress He Has No ‘Remorse’ For Jeffrey Epstein ‘Sweetheart Deal,’ Lawmaker Says appeared on BitcoinEthereumNews.com. Topline A central figure in the Jeffrey Epstein sexual abuse saga—former prosecutor Alex Acosta, who granted in 2007 the former financier what’s been widely blasted as a “sweetheart deal” for his alleged crimes—has no regrets about the agreement, a Democratic lawmaker told CNN on Friday, as the former Trump official faces questioning from the House Oversight Committee. Alex Acosta, center, arrives for a House Oversight Committee deposition about Jeffrey Epstein on September 19 in Washington D.C. CQ-Roll Call, Inc via Getty Images Key Facts This story is breaking and will be updated. Source: https://www.forbes.com/sites/alisondurkee/2025/09/19/prosecutor-acosta-who-gave-epstein-sweetheart-deal-testifies-he-no-remorse-lawmaker-says/
Share
BitcoinEthereumNews2025/09/20 06:37